Squarepoint Ops LLC

Position in DSGN — Design Therapeutics, Inc.

CIK 1642575 NEW YORK, NY

Position in DSGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$916,284

+$483,473 QoQ

Shares Held

86,117

+86.6% QoQ

Ownership

0.138%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Mar 31, 2026

Squarepoint Ops LLC holds $1,099,779,999 across 233 Biotechnology names. DSGN ranks #114 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	426,723	$141,189,839
2	REGN	Regeneron Pharmaceuticals, Inc.	162,814	$125,796,608
3	RPRX	Royalty Pharma plc	1,349,516	$64,736,282
4	IONS	Ionis Pharmaceuticals Inc	695,276	$52,208,274
5	BBIO	BridgeBio Pharma, Inc.	556,324	$41,312,620
6	MDGL	Madrigal Pharmaceuticals, Inc.	52,884	$27,683,187
7	ARQT	Arcutis Biotherapeutics, Inc.	1,103,490	$25,998,224
8	FOLD	AMICUS THERAPEUTICS, INC.	1,705,829	$24,666,287

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$916,284	86,117	+86.6%	Shares	Defined	2026-05-15
2025-12-31	$432,811	46,142	-4.2%	Shares	Defined	2026-02-13
2024-12-31	$297,307	48,186	-43.4%	Shares	Defined	2025-02-14
2024-09-30	$458,004	85,131	-5.4%	Shares	Defined	2024-11-14
2024-06-30	$301,349	89,955	+146.9%	Shares	Defined	2024-08-14
2024-03-31	$146,841	36,437	-5.2%	Shares	Defined	2024-05-15
2023-12-31	$101,836	38,429	-9.7%	Shares	Defined	2024-02-14
2023-09-30	$100,446	42,562	+2.3%	Shares	Defined	2023-11-14
2023-06-30	$262,017	41,590	-61.9%	Shares	Defined	2023-08-14
2023-03-31	$630,164	109,214	+364.9%	Shares	Defined	2023-05-15
2021-03-31	$702,440	23,493	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.